225 related articles for article (PubMed ID: 30598442)
1. Rigidification of the
Zhu Y; Mohapatra S; Weisshaar JC
Proc Natl Acad Sci U S A; 2019 Jan; 116(3):1017-1026. PubMed ID: 30598442
[TBL] [Abstract][Full Text] [Related]
2. Biophysical Properties of Escherichia coli Cytoplasm in Stationary Phase by Superresolution Fluorescence Microscopy.
Zhu Y; Mustafi M; Weisshaar JC
mBio; 2020 Jun; 11(3):. PubMed ID: 32546611
[TBL] [Abstract][Full Text] [Related]
3. Local rigidification and possible coacervation of the Escherichia coli DNA by cationic nylon-3 polymers.
Zhu Y; Liu L; Mustafi M; Rank LA; Gellman SH; Weisshaar JC
Biophys J; 2021 Dec; 120(23):5243-5254. PubMed ID: 34757079
[TBL] [Abstract][Full Text] [Related]
4. Long-term effects of the proline-rich antimicrobial peptide Oncocin112 on the
Zhu Y; Weisshaar JC; Mustafi M
J Biol Chem; 2020 Sep; 295(38):13314-13325. PubMed ID: 32727850
[TBL] [Abstract][Full Text] [Related]
5. Functional mapping of the E. coli translational machinery using single-molecule tracking.
Mohapatra S; Weisshaar JC
Mol Microbiol; 2018 Oct; 110(2):262-282. PubMed ID: 30107639
[TBL] [Abstract][Full Text] [Related]
6. Nonperturbative imaging of nucleoid morphology in live bacterial cells during an antimicrobial peptide attack.
Bakshi S; Choi H; Rangarajan N; Barns KJ; Bratton BP; Weisshaar JC
Appl Environ Microbiol; 2014 Aug; 80(16):4977-86. PubMed ID: 24907320
[TBL] [Abstract][Full Text] [Related]
7. Real-time attack on single Escherichia coli cells by the human antimicrobial peptide LL-37.
Sochacki KA; Barns KJ; Bucki R; Weisshaar JC
Proc Natl Acad Sci U S A; 2011 Apr; 108(16):E77-81. PubMed ID: 21464330
[TBL] [Abstract][Full Text] [Related]
8. The design of antimicrobial LL37-modified collagen-hyaluronic acid detachable multilayers.
Cassin ME; Ford AJ; Orbach SM; Saverot SE; Rajagopalan P
Acta Biomater; 2016 Aug; 40():119-129. PubMed ID: 27109763
[TBL] [Abstract][Full Text] [Related]
9. Expression in Escherichia coli of novel recombinant hybrid antimicrobial peptide AL32-P113 with enhanced antimicrobial activity in vitro.
Wanmakok M; Orrapin S; Intorasoot A; Intorasoot S
Gene; 2018 Sep; 671():1-9. PubMed ID: 29859288
[TBL] [Abstract][Full Text] [Related]
10. Oxidative stress induced in E. coli by the human antimicrobial peptide LL-37.
Choi H; Yang Z; Weisshaar JC
PLoS Pathog; 2017 Jun; 13(6):e1006481. PubMed ID: 28665988
[TBL] [Abstract][Full Text] [Related]
11. Augmentation of the bactericidal activities of human cathelicidin CAP18/LL-37-derived antimicrobial peptides by amino acid substitutions.
Nagaoka I; Kuwahara-Arai K; Tamura H; Hiramatsu K; Hirata M
Inflamm Res; 2005 Feb; 54(2):66-73. PubMed ID: 15750713
[TBL] [Abstract][Full Text] [Related]
12. Acyl carrier protein is a bacterial cytoplasmic target of cationic antimicrobial peptide LL-37.
Chung MC; Dean SN; van Hoek ML
Biochem J; 2015 Sep; 470(2):243-53. PubMed ID: 26188040
[TBL] [Abstract][Full Text] [Related]
13. Synergistic effect of antimicrobial peptide LL-37 and colistin combination against multidrug-resistant
Morroni G; Sante LD; Simonetti O; Brescini L; Kamysz W; Kamysz E; Mingoia M; Brenciani A; Giovanetti E; Bagnarelli P; Giacometti A; Cirioni O
Future Microbiol; 2021 Mar; 16():221-227. PubMed ID: 33646013
[No Abstract] [Full Text] [Related]
14. [Bactericidal activity of GLL-37, a novel derivative of the human antimicrobial peptide LL-37].
Shi L; Liu S; Fan GX; Yuan YK; Mei L
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2008 Jan; 37(1):73-7. PubMed ID: 18275123
[TBL] [Abstract][Full Text] [Related]
15. High level expression and purification of antimicrobial human cathelicidin LL-37 in Escherichia coli.
Krahulec J; Hyrsová M; Pepeliaev S; Jílková J; Cerný Z; Machálková J
Appl Microbiol Biotechnol; 2010 Sep; 88(1):167-75. PubMed ID: 20625720
[TBL] [Abstract][Full Text] [Related]
16. Real-time attack of LL-37 on single Bacillus subtilis cells.
Barns KJ; Weisshaar JC
Biochim Biophys Acta; 2013 Jun; 1828(6):1511-20. PubMed ID: 23454084
[TBL] [Abstract][Full Text] [Related]
17. Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell-selective activity.
Oren Z; Lerman JC; Gudmundsson GH; Agerberth B; Shai Y
Biochem J; 1999 Aug; 341 ( Pt 3)(Pt 3):501-13. PubMed ID: 10417311
[TBL] [Abstract][Full Text] [Related]
18. Dermcidin-derived peptides show a different mode of action than the cathelicidin LL-37 against Staphylococcus aureus.
Senyürek I; Paulmann M; Sinnberg T; Kalbacher H; Deeg M; Gutsmann T; Hermes M; Kohler T; Götz F; Wolz C; Peschel A; Schittek B
Antimicrob Agents Chemother; 2009 Jun; 53(6):2499-509. PubMed ID: 19364862
[TBL] [Abstract][Full Text] [Related]
19. Interaction of Laponite with Membrane Components-Consequences for Bacterial Aggregation and Infection Confinement.
Malekkhaiat Häffner S; Nyström L; Browning KL; Mörck Nielsen H; Strömstedt AA; van der Plas MJA; Schmidtchen A; Malmsten M
ACS Appl Mater Interfaces; 2019 May; 11(17):15389-15400. PubMed ID: 30951282
[TBL] [Abstract][Full Text] [Related]
20. Decoding the functional roles of cationic side chains of the major antimicrobial region of human cathelicidin LL-37.
Wang G; Epand RF; Mishra B; Lushnikova T; Thomas VC; Bayles KW; Epand RM
Antimicrob Agents Chemother; 2012 Feb; 56(2):845-56. PubMed ID: 22083479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
